LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

GBA RNAi but not catalytic inhibition of glucocerebrosidase with Conduritol-β-epoxide increases levels of total α-synuclein in SH-SY5Y cells

Mutations in the glucocerebrosidase gene are a common genetic risk factor for developing Parkinson's disease. The reasons why glucocerebrosidase mutations cause an increased life-time risk of developing Parkinson's disease are… Click to show full abstract

Mutations in the glucocerebrosidase gene are a common genetic risk factor for developing Parkinson's disease. The reasons why glucocerebrosidase mutations cause an increased life-time risk of developing Parkinson's disease are not fully understood. Here, we aimed to verify whether glucocerebrosidase activity has an effect on total α-synuclein levels. We use SH-SY5Y and primary cortical cells and expose them to either Conduritol-β-epoxide or siRNA targeting GBA 1. Unexpectedly, RNA interference towards GBA 1 and catalytic inhibition produce different effects on α-synuclein levels in cellular models.

Keywords: glucocerebrosidase; total synuclein; conduritol epoxide; catalytic inhibition

Journal Title: Neuroscience Letters
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.